194 related articles for article (PubMed ID: 20145061)
1. Role of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy.
Scott PA; Roberts PR
Postgrad Med J; 2010 Feb; 86(1012):116-22. PubMed ID: 20145061
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
3. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E
Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316
[TBL] [Abstract][Full Text] [Related]
4. Sudden cardiac death: opportunities for prevention.
Morgan JM; Cowan JC; Camm AJ; McComb JM
Heart; 2006 Jun; 92(6):721-3. PubMed ID: 16159972
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation.
Buxton AE; Ellison KE; Lorvidhaya P; Ziv O
J Cardiovasc Pharmacol; 2010 May; 55(5):450-5. PubMed ID: 20509178
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis.
Smith T; Jordaens L; Theuns DA; van Dessel PF; Wilde AA; Hunink MG
Eur Heart J; 2013 Jan; 34(3):211-9. PubMed ID: 22584647
[TBL] [Abstract][Full Text] [Related]
7. The high cost of implantable defibrillators.
Hlatky MA; Mark DB
Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
[TBL] [Abstract][Full Text] [Related]
8. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
Kamath GS; Mittal S; Sherrid MV
Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485
[TBL] [Abstract][Full Text] [Related]
9. Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments.
Inama G; Pedrinazzi C; Landolina M; Oliva F; Senni M; Proclemer A; Berisso MZ; Pirelli S;
J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):675-83. PubMed ID: 22002257
[TBL] [Abstract][Full Text] [Related]
10. The implantable cardioverter-defibrillator: does everybody need one?
Raj SR; Sheldon RS
Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276
[TBL] [Abstract][Full Text] [Related]
11. ICD for primary prophylaxis of sudden cardiac death: an Indian perspective.
Naik N; Juneja R
J Assoc Physicians India; 2007 Apr; 55 Suppl():47-53. PubMed ID: 18376491
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
Grimm W; Alter P; Maisch B
Herz; 2004 May; 29(3):348-52. PubMed ID: 15167963
[TBL] [Abstract][Full Text] [Related]
14. Biventricular pacing and defibrillator use in chronic heart failure.
Cesario DA; Turner JW; Dec GW
Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
[TBL] [Abstract][Full Text] [Related]
15. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
[TBL] [Abstract][Full Text] [Related]
16. Benefits of the implantable cardioverter-defibrillator.
Epstein AE
J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from neutral ICD trials.
Nisam S; Breithardt G
Europace; 2006 Jun; 8(6):393-7. PubMed ID: 16670114
[TBL] [Abstract][Full Text] [Related]
18. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy.
Haghjoo M; Arya A; Sadr-Ameli MA
Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic dilated cardiomyopathy--an appraisal in 2005].
Antz M; Bänsch D
Herz; 2005 Mar; 30(2):87-90. PubMed ID: 15875096
[TBL] [Abstract][Full Text] [Related]
20. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
Beggs SAS; Jhund PS; Jackson CE; McMurray JJV; Gardner RS
Heart; 2018 Jan; 104(2):144-150. PubMed ID: 28986406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
